What’s New!
Could Singapore become the next global biotech hub?
Despite planting seeds for decades, Singapore has yet to blossom into a global hub for biotechs. A new wave of international biopharmas setting up shop in the country and an influx of sophisticated, global biotech investors could change that.
What to watch in the biomedical space over the next five years
The pandemic has brought the spotlight onto the healthcare and biomedical sectors, driving unprecedented enthusiasm in the relatively unknown field of mRNA innovations, and bolstering growth in digital health. Yet, the silver lining has dulled investors’ sentiments post-COVID. Increasingly, investors have become more cautious against macroeconomic headwinds, and many are expecting a correction in company valuations across all sectors.
WalkMe Establishes Asia Pacific Headquarters in Singapore
WalkMe, a leading provider of digital adoption platforms, announced the opening of its Asia Pacific headquarters in Singapore. The office was officially opened by Raphael Sweary, President and Co-founder, WalkMe at an exclusive event with senior executives from EDBI and IMDA.
Could Singapore become the next global biotech hub?
Despite planting seeds for decades, Singapore has yet to blossom into a global hub for biotechs. A new wave of international biopharmas setting up shop in the country and an influx of sophisticated, global biotech investors could change that.
- 2 May 2023
EdgeQ Closes $75M Series-B Investment and Ramps to Customers’ Demand for Its Award-Winning 5G+AI Base Station-on-a-Chip for 5G Networks
Lattice Semiconductor CEO Jim Anderson Joins the Board of Directors as the Company Enters into Customer Deployments of Private 5G and Open RAN Networks
- 2 May 2023
Proxtera announces successful first close, of Series Seed round of funding with Ant Group, CerraCap Ventures, and EDBI
The funding will be used as working capital to further develop the company’s innovative digital cross-border trade and financial services enabled by trusted credentials.
- 30 Mar 2023
What to watch in the biomedical space over the next five years
The pandemic has brought the spotlight onto the healthcare and biomedical sectors, driving unprecedented enthusiasm in the relatively unknown field of mRNA innovations, and bolstering growth in digital health. Yet, the silver lining has dulled investors’ sentiments post-COVID. Increasingly, investors have become more cautious against macroeconomic headwinds, and many are expecting a correction in company valuations across all sectors.
- 23 Feb 2023
Senior management changes at EDBI
EDBI announces changes to management that will take effect from 1 February 2023.
- 28 Nov 2022
Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion
The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS Capital, Alafi Capital, and NRW.BANK, as well as other existing investors.
- 24 Oct 2022
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors. Anzu Partners led the $14M financing round with participation from Amgen Ventures and EDBI.
- 20 Sep 2022
Fazz Secures $100M in Series C to Power Financial Inclusion in SEA
Fresh investment from prominent investors will propel Fazz into a new season of growth and further accelerate the future of Business Finance in Southeast Asia.
- 14 Sep 2022
The Sustainable Recipe to Feed the World
Dive into China and Southeast Asia's agrifood landscape, and what the future holds
- 12 Sep 2022
The Perks of Investing in Real Time Data
A video interview by Singapore Business Review featuring Deb Dutta (DataStax) and Paul Ng (EDBI) on how real time data applications can help organisations innovate and adopt technologies to build a smarter Singapore.
- 7 Sep 2022
